Percutaneous Implantation of Autologous Bone Marrow Osteoprogenitor Cells as Treatment of Bone Avascular Necrosis Related to Sickle Cell Disease

The treatment of bone a vascular necrosis is a big challenge considering the youthfulness of the patients involved by necrosis in sickle cell disease and the importance of the generated disability. A vascular osteonecrosis is an epiphysis pathology which could be treated by joint replacement with success, however, multiple surgical procedures are mostly necessary during the patient’s life with a hazardous long term functional results. The treatment by autologous bone marrow grafting is an effective alternative which preserve the native joint. Using this mini-invasive high technology surgical treatment in early stages, a joint replacement could be avoided in many patients.

• Publication year

  2008

• Venue

  The Open Orthopaedics Journal

• Publication date

  2008-04-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1874325000802010062PMID 19478932PMCID 2687112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The philosophy of scientific experimentation: a review

  2009cited by this paper
• Bone involvement in sickle cell disease

  2005cited by this paper
• Sickle-cell disease.

  2004cited by this paper
• Current concepts review: Engineering principles of clinical cell-based tissue engineering

  2004cited by this paper
• Core decompression for osteonecrosis of the hip.

  2004cited by this paper
• The Natural History of Symptomatic Osteonecrosis in Adults with Sickle-Cell Disease

  2003cited by this paper
• Treatment of Osteonecrosis With Autologous Bone Marrow Grafting

  2002cited by this paper
• Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management

  2001cited by this paper
• The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head.

  2001cited by this paper
• Management of sickle cell disease.

  1999cited by this paper
• Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis.

  1999cited by this paper
• Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells

  1998cited by this paper
• Mesenchymal stem cells in osteobiology and applied bone regeneration.

  1998cited by this paper
• Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up.

  1997cited by this paper
• Sickle cell disease.

  1996cited by this paper
• A quantitative system for staging avascular necrosis.

  1995cited by this paper
• Characterization of cells with osteogenic potential from human marrow.

  1992cited by this paper
• Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients.

  1991cited by this paper
• Sickle cell disease as a cause of osteonecrosis of the femoral head.

  1991cited by this paper
• Orthopaedic manifestations of sickle-cell disease.

  1990cited by this paper
• Total replacement of the hip for avascular necrosis in sickle cell disease.

  1989cited by this paper
• Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy.

  1988cited by this paper
• Management of sickle-cell disease

  1974cited by this paper
• Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation.

  1969cited by this paper
• Bone and Joint Lesions in Sickle‐Cell Disease

  1967cited by this paper
• Gene Mutations in Human Hæmoglobin: the Chemical Difference Between Normal and Sickle Cell Hæmoglobin

  1957cited by this paper

• IMPORTÂNCIA DA TERAPIA CELULAR NA OSTEONECROSE DA CABEÇA UMERAL RECUPERAÇÃO DA BIOMECÂNICA DO OMBRO

  2025cites this paper
• Surgical Treatment of Osteonecrosis of the Femoral Head Using Minimally Invasive Surgical Drilling and Cancellous Grafting at Brazzaville University Hospital

  2024cites this paper
• Therapy with bone marrow mesenchymal stem cells in bone regeneration in children with osteonecrosis secondary to sickle cell disease

  2024cites this paper
• Short-term Follow-up of Autologous Adult Live-Cultured Osteoblasts Implantation in Avascular Necrosis of Femoral Head Secondary to Sickle Cell Anemia-Case Series

  2023cites this paper
• Correlation between skeletal manifestations of sickle cell disease (SCD) and transcranial doppler imaging velocities

  2023cites this paper
• Core Decompression and Bone Marrow Aspirate Concentrate in the Treatment of Femoral Head Avascular Necrosis in Pediatric Sickle Cell Disease: Can We Improve Natural History?

  2021cites this paper
• Use of Bone Marrow Concentrate to Treat Pain and Musculoskeletal Disorders: An Academic Delphi Investigation.

  2021cites this paper
• Physiopathologie de la drépanocytose homozygote

  2020cites this paper
• Total hip arthroplasty for sickle cell osteonecrosis: guidelines for perioperative management

  2020cites this paper
• Bone marrow aspirate concentrate (Stem cells) therapy for pre-collapse stage of AVN of femoral head: An interventional comparative study

  2020cites this paper
• PAST, CURRENT AND FUTURE INTERVENTIONAL ORTHOBIOLOGICS TECHNIQUES AND HOW THEY RELATE TO REGENERATIVE REHABILITATION: A CLINICAL COMMENTARY.

  2020cites this paper
• The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases

  2020cites this paper
• Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease

  2019cites this paper
• Use of autologous bone marrow stem cell implantation for osteonecrosis of the knee in sickle cell disease: a preliminary report

  2018cites this paper
• Management of Sickle Cell Anemia

  2018cites this paper
• Management of osteonecrosis of the femoral head in children with sickle cell disease: results of conservative and operative treatments at skeletal maturity

  2018cites this paper
• Looking into the Future: Toward Advanced 3D Biomaterials for Stem‐Cell‐Based Regenerative Medicine

  2018cites this paper
• Increased Internal Porosity and Surface Area of Hydroxyapatite Accelerates Healing and Compensates for Low Bone Marrow Mesenchymal Stem Cell Concentrations in Critically-Sized Bone Defects

  2018cites this paper
• Analysis of Cell Therapies Used in Clinical Trials for the Treatment of Osteonecrosis of the Femoral Head: A Systematic Review of the Literature.

  2017cites this paper
• Long-term results of rotational acetabular osteotomy for osteonecrosis with collapse of the femoral head in young patients

  2017cites this paper
• Current Procedures and Techniques for the Treatment of Osteonecrosis of the Hip

  2017cites this paper
• Autologous stem cell‐based therapy for sickle cell leg ulcer: a pilot study

  2016cites this paper
• Clinical Manifestations and Treatment of Adult Sickle Cell Disease

  2016cites this paper
• Autologous Bone Marrow Concentrate in a Sheep Model of Osteoarthritis: New Perspectives for Cartilage and Meniscus Repair

  2016cites this paper
• The role of mesenchymal stromal cells in the management of musculoskeletal disorders

  2016cites this paper
• The Current State of Stem Cell Therapies in Sports Medicine

  2016cites this paper
• Stem Cell Considerations for the Clinician.

  2016cites this paper
• Core decompression or quadratus femoris muscle pedicle bone grafting for nontraumatic osteonecrosis of the femoral head: A randomized control study

  2016cites this paper
• Circulating Progenitor Cells in Regenerative Technologies: A Realistic Strategy in Bone Regeneration?

  2016cites this paper
• Musculoskeletal Manifestations of Sickle Cell Disease: A Review

  2015cites this paper
• Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study

  2015influential citation
• Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease.

  2015cites this paper
• Non-Hematopoietic Essential Functions of Bone Marrow Cells: A Review of Scientific and Clinical Literature and Rationale for Treating Bone Defects

  2015cites this paper
• Three-dimensional culture of mesenchymal stem cells

  2015cites this paper
• Bone marrow concentrate and platelet-rich plasma acquisition and preparation: Why technique matters

  2015cites this paper
• Osteogenic efficacy of bone marrow concentrate in rabbit maxillary sinus grafting.

  2014cites this paper
• Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: a systematic review

  2014cites this paper
• Repair of orbital bone defects in canines using grafts of enriched autologous bone marrow stromal cells

  2014cites this paper
• Preliminary Results of Multiple Epiphyseal Drilling and Autologous Bone Marrow Implantation for Osteonecrosis of the Femoral Head Secondary to Sickle Cell Disease in Children

  2014cites this paper
• Skeletal Resident Stem Cells

  2013cites this paper
• Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

  2013cites this paper
• Treatment Options and Outcomes

  2013cites this paper
• Osteonecrosis of the hip: treatment options and outcomes.

  2013cites this paper
• METHODS TO QUANTITATIVELY ASSESS THE PERFORMANCE OF CONNECTIVE TISSUE PROGENITOR CELLS IN RESPONSE TO SURFACE MODIFIED BIOMATERIALS

  2013cites this paper
• Clinical management of adult sickle-cell disease

  2012cites this paper
• Core decompression combined with implantation of a demineralised bone matrix for non-traumatic osteonecrosis of the femoral head

  2012cites this paper
• Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss.

  2012cites this paper
• Stem Cells for Augmenting Tendon Repair

  2011cites this paper
• Seeding a human tendon matrix with bone marrow aspirates compared to previously isolated hBMSCs – An in vitro study

  2011cites this paper
• The use of BoneWelding® technology in spinal surgery: an experimental study in sheep

  2011cites this paper
• Bone & Cartilage Regeneration News 01 11

  2011cites this paper
• MANIFESTAÇÕES OSTEOARTICULARES NA ANEMIA FALCIFORME

  2010cites this paper
• [Cell therapy in bone-healing disorders].

  2010cites this paper
• Sickle-cell disease

  2010cites this paper
• Zelltherapie bei Knochenheilungsstörungen

  2010cites this paper
• Cell therapy in bone healing disorders

  2010cites this paper
• Treatment of sickle cell disease's hip necrosis by core decompression: a prospective case-control study.

  2009cites this paper
• Traitement de l'ostéonécrose drépanocytaire par forage de la tête fémorale

  2009cites this paper
• Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients

  2009cites this paper
• E�cacy of cell therapy for osteonecrosis of the hip compared with hip arthroplasty in sickle cell disease: a systematic review

  year unknowncites this paper